Copying May Show Nonobviousness Even If No Specific Product Is Copied
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
LIQWD, INC. v. L'OREAL USA, INC.
Before Reyna, Hughes, and Stoll. Appeal from the Patent Trial and Appeal Board.
Summary: Evidence of copying was relevant to nonobviousness even though the copied feature came from an unpublished patent application rather than a product.
L’Oreal filed a petition with the Patent Trial and Appeal Board for post grant review of a Liqwd patent, asserting obviousness. The patent covered a method for bleaching hair. Liqwd presented evidence that L’Oreal copied parts of Liqwd’s method from an unpublished patent application that Liqwd disclosed to L’Oreal under a nondisclosure agreement. The Board found that L’Oreal engaged in such copying, but held that it was irrelevant to obviousness. To make the copying relevant, the Board believed Liqwd would need to show that L’Oreal copied a “specific product” that embodied the claimed invention. In the end, the Board concluded the patent was obvious. Liqwd appealed.
The Federal Circuit held that the Board’s decision to disregard the copying evidence was error. The Federal Circuit explained that the relevance of copying evidence does not turn on whether a specific product was copied. To prove copying, the evidence must show that a party duplicated features of the patentee’s work based on access to the work. The Board found such copying, but failed to weigh that copying in its obviousness analysis. Accordingly, the Federal Circuit vacated the Board’s decision and remanded with instructions for the Board to weigh the copying appropriately.
Editor: Paul Stewart
Written by: Derk Westermeyer & Jeremy Anapol
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…